FDA OKs Medtronic's Melody HDE In First Transcatheter Valve Approval
This article was originally published in The Gray Sheet
Medtronic's Melody percutaneous pulmonary heart valve is the first transcatheter heart valve available in the U.S. following FDA humanitarian device exemption approval, announced Jan. 25
You may also be interested in...
New results were reported on heart valves, cardiac rhythm management devices, and biodegradable coronary stents at the 2014 American College of Cardiology Scientific Sessions in Washington, D.C.
The full results of Medtronic’s SYMPLICITY HTN-3 trial, to be presented at the American College of Cardiology Scientific Sessions on March 29, could determine the fate of the renal denervation devices under development by several major companies for drug-resistant hypertension.
FDA wants to better understand computer modeling methods - such as programs that simulate the performance of heart valves in the body - and help companies incorporate such tests into pre-market device applications